By Ryan Davis ( March 22, 2016, 8:03 PM EDT) -- The Federal Circuit's decision that generic-drug makers can be sued for patent infringement wherever they plan to make sales resolves confusion about venue caused by a recent U.S. Supreme Court ruling and means most suits will still be filed in Delaware and New Jersey, attorneys say....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.